Berberine
Berberine may lower glucose while GHRP-2 can affect glucose and appetite.
Recommendation: Avoid unsupervised stacking; monitor glucose if a clinician is supervising endocrine testing.
Peptide ·Insufficient evidence ·Reviewed May 2026
GHRP-2, also called pralmorelin, is a synthetic hexapeptide ghrelin receptor agonist that stimulates growth hormone release. It is approved in Japan for diagnostic assessment of growth hormone deficiency, but it is not FDA-approved for human use in the United States and is not approved for anti-aging, bodybuilding, fat loss, or wellness protocols. Long-term therapeutic evidence is limited, and risks include appetite change, glucose effects, cortisol or prolactin elevations, edema, and WADA-prohibited status.
The bottom line
Evidence rating insufficient. Most-documented uses: acutely stimulates gh release in diagnostic or research settings, approved in japan for gh deficiency diagnostic testing, may increase appetite. 3 sources indexed (1998–2005), with 3 interaction records on file.
Core mechanism
GHRP-2 activates GHS-R1a receptors in the pituitary and hypothalamus to stimulate GH pulses through a pathway distinct from GHRH. It can also influence ACTH, cortisol, prolactin, appetite, and gastric signaling because the ghrelin receptor is not restricted to somatotrophs. Repeated dosing may attenuate GH response, and acute hormone elevation does not prove durable clinical benefit.3,1
Peptide use in studies is parenteral. Nonsterile or research-grade injection is unsafe.
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Research peptide vial.
Research-market pricing is not a recommendation for human use. Updated 2026-06-04.
Dose: Jurisdiction-specific diagnostic protocol2
Timing: Endocrinology clinic protocol
Not a treatment or wellness dose.
Dose: No FDA-approved dose
Timing: Not applicable
Long-term outcome evidence is inadequate and use is prohibited in sport.
Dose: No approved US dose
Timing: Not applicable
Hunger is a pharmacologic effect and may worsen metabolic risk.
What to test, the optimal window inside the conventional range, and how long a response takes.
May or may not increase with repeated use; short studies show possible response attenuation.3,1
Do not use for unsupervised research peptide decisions.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Ghrelin receptor activation can increase food intake acutely.1
Not an approved appetite medication in the US.
Acutely stimulates GH, but repeated short exposure may not raise IGF-1.3,1
Endocrinology evaluation is required.
Performance claims are extrapolated from GH pulses, not proven outcomes.
WADA-prohibited.
Berberine may lower glucose while GHRP-2 can affect glucose and appetite.
Recommendation: Avoid unsupervised stacking; monitor glucose if a clinician is supervising endocrine testing.
Alpha-lipoic acid affects insulin sensitivity while GHRP-2 may alter glucose handling.
Recommendation: Use glucose monitoring in any supervised context and avoid research-product self-use.
Creatine water weight can obscure edema or rapid weight changes from GH secretagogue use.
Recommendation: Track edema symptoms, blood pressure, and glucose rather than interpreting scale weight alone.
Numbered references. Citations throughout the page link here.
GHRP-2 infusion increased ad libitum food intake in a small study of healthy men.
Review summarized pralmorelin development and clinical diagnostic context.
Daily GHRP-2 caused attenuation of GH response and did not raise IGF-1 over 5 days.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.